Neonatal Opioid Withdrawal Syndrome (NOWS), formerly known as Neonatal Abstinence Syndrome (NAS), refers to the collection of signs and symptoms that may occur in opioid-exposed newborns shortly after birth. Between 2010 and 2013, the number of infants with NOWS doubled with a total cost exceeding $23 million in Alabama.

The ALPQC aims to reduce variation in treatment, and optimize the care of infants with NOWS through compassionate withdrawal treatment with the goal of optimizing nonpharmacologic management, pharmacologic management, and providing a safe discharge for these infants and mothers.  

To that end, we’ve developed a toolkit that utilizes evidence-based and standard practices used by other perinatal quality collaboratives. We recognize that each hospital is unique and not all of these factors need to be addressed in every facility. Therefore, it is important to use this toolkit to determine what might be relevant to your facility.

The kickoff and onboarding for this Initiative took place at the ALPQC Annual Summit on February 27th, 2020. The Summit agenda and linked slides can be found at the bottom of this page.

To enroll in the NOWS Initiative, please click here.

After enrollment, you will be added to the Alabama Hospital Association (AlaHA) Quality Data Portal and given instructions for creating a username and password. 

Click the links below for more information on the initiative:

Resources to Help with Data Collection:

Other Resources:

For any questions, contact Sam GentleEvelyn Coronado-Guillaumet, Rosemary Blackmon, or Margaret Borders